Morgia, Marilyn .

HRN: 26-66-75  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/22/2025
03/24/2025
IV
500mg
Q8hrs X 6 Doses
S/P Primary LTCS
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: